A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants
Clinical trial NCT04965402 · COMPLETED
Trial details
- NCT number
- NCT04965402
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2022-02-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.